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ABSTRACT
CLASSIFICATION OF HYPERSPECTRAL COLON CANCER IMAGES USING
CONVOLUTIONAL NEURAL NETWORKS
by Sean J. Mobilia
Hyperspectral images are 3-D images, which contain data in hundreds of spectral
bands as opposed to 2-D images, which contain data in at most 3 bands (red, green, and
blue). Hyperspectral imagery was initially developed for remote sensing; however,
recently, researchers have started to see its potential in medical diagnosis and cancer
detection. Hyperspectral images provide massive amounts of data about the objects they
are studying, and this causes challenges during information processing. Machine learning
tools, such as convolutional neural networks (CNNs), are known to be successful in
extracting features and classifying traditional 2-D images. This thesis proposes CNN
architectures for processing hyperspectral data for colon cancer detection. Using data
taken from a limited number of colon tissue samples, this thesis shows that the proposed
CNN architecture can classify cancerous and noncancerous tissue samples utilizing
hyperspectral information. The obtained results are compared to grayscale images of the
same tissue samples, looking both at grayscales of the individual hyperspectral bands and
panchromatic grayscale images in which the spectral bands are merged together. The
CNN using the hyperspectral data shows advantages over the grayscale data, with a 5.6%
improvement in accuracy and a 0.037 improvement in F1 score over the individual band
grayscale images and a 21.7% improvement in accuracy and a 0.178 improvement in F1
score over the panchromatic grayscale images. The results are also compared to a
K-nearest neighbor (KNN) classifier and a logistic regression (LR) classifier using the
hyperspectral data, and the CNN shows advantages over both. The CNN has a 17.9%
improvement in accuracy and a 0.141 improvement in F1 score over the KNN classifier
and a 5% improvement in accuracy and a 0.061 improvement in F1 score over the LR
classifier.
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1 INTRODUCTION
Across the globe, cancer is one of the leading causes of death among all age groups. It
can affect anyone, and just about every person has either had it, or known someone who
has had it. Among people in the United States, colon cancer is the second largest cause of
cancer deaths [1]. Colon cancer symptoms can be difficult to detect at first, as many of the
early symptoms may seem like common ailments. Colon cancer is diagnosed in the
localized stage, the earliest stage in which the cancer is smallest, 38% of the time. It is
diagnosed in the regional stage, in which the cancer has spread throughout the organ, 36%
of the time. And it is diagnosed in the distant stage, in which the cancer has spread
throughout the body into other organs, 22% of the time [2]. Fig. 1 shows the stages of
colon cancer when it is first diagnosed.
Fig. 1. Colon cancer stage at diagnosis. Data are provided by Siegel et al. [2].
As with many forms of cancer, early screening and diagnosis significantly increase the
patient’s chance of survival. Fig. 2 shows colon cancer survival rates at different stages of
diagnosis. If caught early, the 5-year survival rate for colon cancer can be as high as
91.1%; however as the cancer spreads, the rate drops significantly. If cancer is diagnosed
in the distant stage, the survival rate falls to 13.3% [2]. Current screening methods are
missing too many cases until the cancer has spread into other parts of the body, so an
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improvement to these methods is needed. One of the areas being explored is the use of
hyperspectral imaging to aid in early cancer detection and research [3].
Fig. 2. Colon cancer survival rates by stage detected. Data are provided by Siegel et al.
[2].
Hyperspectral imaging involves imaging data that take a detailed look at the
electromagnetic spectrum in order to learn more detail about the subject being studied.
Initially developed for remote sensing satellite instruments, hyperspectral imaging
provides a wealth of information about the material composition of the subject being
studied [4]. With advancements in sensor size and computation power, this imaging is
finding more applications in laboratory research and commercial industries.
Hyperspectral images contain a tremendous amount of information. Many typical
hyperspectral imagers create hundreds of spectral bands with each image. This huge
amount of data can be difficult to process and examine with traditional image processing
tools. Artificial neural networks (ANNs) can be used to extract the relevant information
from this complex dataset. First developed in the 1940s, ANNs are programs modeled
after brains [5]. ANNs involve the use of hidden computational layers to extract deeper
features and relationships between different inputs. These hidden layers allow ANNs to
move beyond basic tasks [6]. ANNs that have two or more of these hidden layers are
2
known as deep neural networks (DNNs). The popularity of these networks has been
growing recently due to the DNN’s ability to handle increasingly complex tasks, such as
speech recognition, prediction of molecule interaction, image segmentation, and
classification, thanks to the advances in computational tools [6], [7]. Convolutional neural
networks (CNNs) are special kinds of DNNs that make use of discrete convolutions to
process large datasets and extract features from them. These networks are especially
useful when it comes to image classification, due to the convolutional layers picking out
abstract features independently of where they are located in the image.
The purpose of this thesis is to demonstrate the use of CNNs in processing
hyperspectral imaging data for classifying colon cancer images. This will be accomplished
by training a CNN to classify hyperspectral colon tissue samples and then comparing the
results to a similar CNN trained on grayscale images generated by the same test samples.
The output from the CNN will also be compared to the output from simple classifiers, to
show that deep learning tools were beneficial in classifying the data. The remainder of
this thesis is structured as follows. Chapter 2 will cover some necessary background
related to hyperspectral imaging and CNNs. Chapter 3 will introduce some of the latest
trends in cancer detection, including some applications making use of hyperspectral
technology. Chapter 4 will discuss how the data used in this study were collected.
Chapter 5 will present how the CNN was developed and implemented. Chapter 6 will
present the results of the study and discuss the performance of the CNN. In Chapter 7, we
will discuss the future work. Finally, in Chapter 8, we will present the conclusions.
3
2 BACKGROUND
This chapter presents the necessary background for hyperspectral imaging, beginning
with an overview and explanation of what hyperspectral imaging is. The chapter will then
discuss some of the methods for processing hyperspectral imaging data that are available,
and then it will discuss some of the applications of hyperspectral imaging data and why
they are relevant. This chapter also presents the relevant background on CNNs, discussing
their development, key features, and implementation.
2.1 What is a Hyperspectral Image?
Humans are able to visualize only a small part of the electromagnetic spectrum. The
light emitted by different objects and materials has its own electromagnetic signature, and
since the 1960s, sensors have been used that simultaneously gather information on both
the visible and invisible parts of the spectrum to better collect these signatures.
Hyperspectral imaging involves sensors that look at several narrow bands of the
electromagnetic spectrum [8]. This allows the sensor to catch subtle shifts that are not
noticed by traditional imaging systems. These bands can range between 2 – 10 nm each
and can cover the ultraviolet, visual, near-infrared and short-wave infrared portions of the
spectrum. These images tend to be both spectrally and spatially smooth (the neighboring
pixels and the neighboring bands tend to be highly correlated) [4]. A visual representation
of these bands, called a hypercube, is shown in Fig. 3 using the colon cancer imaging data
discussed in Chapter 4. The light captured by a hyperspectral imager is usually made up
of a collection of constituent spectra, called endmembers. These spectra get mixed
together by a combination of atmospheric effects, spatial resolution of the imager, or the
presence of gaseous mixtures in the medium [4]. The endmembers represent the pure
materials captured in the image [9]. The materials considered a pure material in an image
may vary based on the subject being studied. Highly reflective materials can also change
4
what proportions of endmembers are actually being measured. This can add to the
challenge and complexity of analyzing hyperspectral data.
Fig. 3. Color representation of hyperspectral cube.
2.1.1 Processing of Hyperspectral Images
The high dimensionality and large amounts of data associated with hyperspectral
images create a unique set of challenges for processing and analysis. This section will
discuss some of the methods that have been developed to handle hyperspectral images,
such as hyperspectral data fusion, spectral unmixing, and classification.
Data fusion is the processing technique in which spatial and spectral information is
fused with one or more sources [4]. These techniques are generally implemented in order
to improve the spatial resolution of an image (or at least clear up the noise). Data fusion
techniques tends to be used more with hyperspectral satellite imagery, as there would be
other available datasets to merge with.
There are three main types of hyperspectral data fusion: restoration, spectral data
fusion, and spatial data fusion. Restoration involves the extension of traditional image
de-noising techniques by taking advantage of the high spectral redundancy in the spectral
bands. This merely preserves the original spatial and spectral resolutions and does not
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improve upon them. Spectral data fusion involves fusing together hyperspectral bands, in
order to reduce some of the inherent redundancy in the system. Spatial data fusion
involves methods of improving the spatial resolution of an image by inferring information
at the subpixel level [4]. This can be done by either subsampling the pixels in the image
or by fusing the image with another image of higher spatial resolution.
Hyperspectral unmixing refers to process in which the pixel spectra are separated into
endmember signatures [9]. These processes are trying to untangle different collected
spectra into their pure components. Unmixing methods are often dependent on
assumptions about the object or area being imaged. The linear unmixing model assumes
that endmember abundances are associated with a percentage of the material the
endmember represents. This tends to hold when the system being monitored is
macroscopic. Linear mixing tends to occur in the hyperspectral instrument due to low
spatial resolution. Nonlinear mixing tends to occur due to interactions in the atmosphere,
occurring when light is reflected off of an object [9].
Hyperspectral classification is another common way to process hyperspectral imagery.
One of the key aspects of hyperspectral classification is feature mining, the ability to
extract features from the fine details. Some typical classification tools for hyperspectral
imagery involve principal components analysis (PCA), support vector machines, linear
discriminant analysis and quadratic discriminant analysis [4].
2.1.2 Applications of Hyperspectral Images
Advancements in technology have allowed hyperspectral imaging to expand beyond
remote sensing satellites. Smaller camera sizes and more efficient storage have opened up
the potential of unmanned aerial vehicle (UAV) and ground based commercial and
research opportunities involving hyperspectral imaging. Precision agriculture is one of the
potential applications hyperspectral imaging. With access to UAVs, farmers can use
hyperspectral images to better monitor their crops. Hyperspectral images can help detect
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disease, water stress levels, crop nutrients and invasive insects, as well as nutrient
deficiencies and soil contaminants. This allows farmers to catch these problems well
before the first obvious visual symptoms appear [8]. Fresh water resource management is
another potential application of hyperspectral imaging. Hyperspectral imaging can help
provide accurate estimates of the available ground water and can help provide accurate
early warning and flood monitoring. It can also provide information on the quality of
water available. Hyperspectral imaging can be used to catch any biological or biochemical
contaminant and can measure the chemical oxygen and concentration of chlorophyll in
the water [8].
Hyperspectral imaging also has many defense and homeland security related
applications. Hyperspectral anomaly detection methods can easily distinguish between
targets and the background. On the ground, hyperspectral imaging can be used as a tool
for facial recognition, using a combination of classification techniques such as support
vector machines and linear unmixing [8]. It also can be used in facial stress detection, by
detecting changing blood oxygen levels in a subject.
Hyperspectral imaging is also finding more use on the ground, in applications
involving food safety and quality. The rich amount of spatial and spectral information
present in these images make them ideal for analyzing food quality and detecting spoilage
and contaminants. Hyperspectral imaging has been used to assess the firmness of
blueberries and the fat content of pork chops [8]. Hyperspectral imaging also has art and
forensic applications. The spectral signatures can be helpful in detecting forgeries and can
help to authenticate the value of certain pieces [8]. Hyperspectral imaging also has many
medical diagnostic based applications, such as bruise and burn detection, cancer
screening, and surgery assistance [10]. Hyperspectral imaging has also been shown to be
useful in detecting bleeding, diabetes, and several forms of cancer. It is being tested as a
potential alternative to computed tomography and magnetic resonance imaging [8].
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2.2 A Brief Overview of CNNs
The development of CNNs was inspired based on studies of the visual cortex of
mammals [7]. These studies showed that each of the visual cortex neurons reacted to only
a limited portion of the animal’s field of vision. These neurons would react differently to
different visual features. These studies paved the way for the architecture of LeNet-5,
developed in LeCun et al. [11]. This architecture is implemented by using a combination
of convolution layers, which extract features from the input, and pooling layers, which
subsample the input. A visual representation of a CNN architecture is shown in Fig. 4.
From left to right in the figure, the input is shown having the features extracted by the
various layers of the network.
Fig. 4. Visualization of CNN architecture for proposed hyperspectral classifier.
CNN architecture makes use of the properties of sparse interactions, local receptive
fields, parameter sharing, equivarient representation, and sub-sampling to create these
powerful models [6], [11]. The property of sparse interactions means that the weights of
each convolution layer are not fully connected to the layers being fed into them. CNNs
employ sparse interactions by making use of kernels with smaller sizes than the inputs.
This leads to fewer weights and allows the networks to be programmed more efficiently.
Sparse interactions tie into the property of local receptive fields, in which each output
receives inputs from a small portion of neighboring inputs. This allows the subsequent
layers to extract deeper and more abstract features from the input. Another useful property
of CNNs is parameter sharing. Typically, in ANNs, each weight is used by one element of
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the input. For large images, this would lead to rather costly networks. However, for CNNs,
the weights related to one portion of the input are reused for each of the other inputs.
Combined with sparse interactions, these two properties help reduce the size of CNNs and
make them into a valuable tool for learning larger inputs. The property of equivarient
representation, in which changes to the input lead to similar changes in the output, is also
an important property of CNNs. This property is useful for extracting certain features,
such as edges in an image [6]. Sub-sampling helps to further reduce the size of the feature
maps and makes CNNs much more efficient [11].
As CNNs are based on the visual cortex, they naturally excel at visual tasks. As well
as being used for self-driving cars, image classification, and other visual tasks, CNNs
have been also used in voice recognition and natural language processing applications [7].
CNNs are made up of a number of convolutional layers, which are sparsely connected
to the previous layer by a kernel. This limited connection over a local field is what allows
CNNs to extract features from the input data [7]. This kernel sweeps over the input to the
convolution layer, and in doing so, the convolution layer implements 2-D convolution on
the input layer. This is given as
S(i, j) = (K ∗ I)(i, j) =∑
m
∑
n
I(i−m, j−n)K(m,n). (1)
Many machine learning algorithms actually implement a related function, the
cross-correlation function, to avoid having to flip the kernel. The cross-correlation
function is given as
S(i, j) = (K ∗ I)(i, j) =∑
m
∑
n
I(i+m, j+n)K(m,n). (2)
In practice this is acceptable because the machine learning algorithm will just learn the
values of the flipped kernel [6]. The Python module Tensorflow uses cross-correlation to
implement convolution in its functions.
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The convolution layer is generally followed by an activation function. Some common
activation functions are shown in Fig. 3. Typically the relu function is the most popularly
used activation function; however some networks such as LeNet-5 have been known to
use the tanh function [11].
Fig. 5. Common activation functions used in CNNs.
The other main part of a CNN is the pooling layer. The goal of these layers is to
shrink the input down to prevent overfitting on the network. The kernel on these layers
10
has no weights and uses an aggregation function to shrink the size of the input. Most
CNNs make use of max pool layers, which take the maximum value at the kernel as it
passes over the input. The remaining inputs are dropped [7].
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3 LITERATURE REVIEW
This chapter will provide a background of previous work done in hyperspectral
imagery and machine learning tools related to cancer detection. First, the chapter will
discuss machine learning tools and their use in cancer detection. The chapter will then
discuss hyperspectral imagery and machine learning tools used in tandem to detect cancer
cells.
3.1 Machine Learning and Cancer Detection
The most popular machine learning tools for cancer detection are support vector
machines, random forests, Bayesian networks, and CNNs. Bazazeh and Shubair [12]
showed that mammogram images can be used with support vector machines and random
forests to detect breast cancer. Alam et al. [13] used computerized tomography scans with
support vector machines to classify lung cancer.
CNNs have recently been applied as a tool in cancer diagnosis. Tan et al. [14]
discussed using CNNs to help detect breast cancer using grayscale mammogram images.
Godkhindi and Gowda [15] developed colon cancer detection methods with K-nearest
neighbor (KNN) algorithms, random forests, and CNNs for use with grayscale computed
tomography colonography images. Chiang et al. [16] used 3-D ultrasound images to
improve breast cancer detection using a 3-D CNN.
3.2 Hyperspectral Imaging and Cancer Detection
As hyperspectral imaging is becoming more widespread in commercial and research
applications, it is finding new uses as a tool for medical diagnosis. Lu and Fei [10] have
discussed the use of hyperspectral imagery and its role in medical diagnostics and as a
tool for image-guided surgery. They also discussed several hyperspectral systems that
have been develop to detect and screen for different types of cancer, such as skin, breast,
gastric, cervical, and prostate cancers. Many of these cancer detection applications focus
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on the visible parts of the spectrum, especially focusing on the blue and green
wavelengths. It has been shown in Leavesley et al. [17] that for colon cancer, the
blue-violet portion of the spectrum (390 nm – 450 nm) has the highest correlation with
instances of cancer.
Machine learning and hyperspectral images have been combined to create a system of
new, noninvasive forms of cancer detection [3], [10], [17]–[23]. Support vector machines
and minimum spanning forests have been used to analyze hyperspectral data [19]–[21]
with PCA having been used for feature reduction to improve the algorithms [19]. Rathore
et al. [3] discussed methods for hyperspectral colon cancer detection using support vector
machines, PCAs, and linear discriminant analysis. Lu et al. [18] used a combination of
spatial and spectral data to improve non-invasive head and neck cancer detection
techniques, using support vector machines and PCAs. Pike et al. [20] used tumor-bearing
mice to test out the hyperspectral classification of head and neck cancer using minimum
spanning forests. Gopi and Reshmi [21] developed a method combining minimum
spanning forests with support vector machines, and applied it in order to detect cancer on
various animals.
Hyperspectral imaging has also been increasingly used in conjunction with neural
network models to improve forms of cancer detection. Along with using support vector
machines, Leavesley et al. [22] has used an ANN to classify colon cancer images using
hyperspectral fluorescence. Nathan et al. [19] has also explored using an ANN with
hyperspectral imagery to classify cancer data. Ma et al. [23] have used CNNs in the pixel
classification of hyperspectral images in order to detect head and neck cancer. They turned
the spectra of the image from each pixel into a 16 × 16 patch and fed this into a CNN.
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4 HYPERSPECTRAL COLON CANCER DATA
In this chapter we discuss the hyperspectral data that are used in this research. In the
first section, we discuss how the colon tissue samples were gathered. In the next section,
we discuss the imager that was used to gather the data. In the final section of the chapter,
we discuss the distribution of the data that were collected.
The colon cancer tissues samples that are used in this research were gathered as
previously described in Deal et al. [24] from the University of South Alabama Medical
Center Department of Surgery. This dataset is not publicly available and is used as part of
a collaboration with researchers at the University of South Alabama. During the surgery,
the tumorous growth was removed along with a section of normal tissue. The samples
were then taken to pathology where they were bisected, with one half frozen and analyzed
and the other half stored for imaging. The half stored for imaging were returned in cups
marked “lesional” and “normal” and then rinsed and cut into 2 cm cubes. Each of the
samples was imaged within 8 hours of being resectioned. An example of one of these
tissue samples is shown in Fig. 6. Each tissue sample had images taken from at least two
fields of view at the lab.
Fig. 6. Example of tissue sample studied with the hyperspectral imager. Image provided
by University of South Alabama researchers.
The collected colon tissue samples were imaged with QImaging Corporation’s Rolera
EM-C2 camera at the laboratory, using the excitation wavelength tuning method described
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in Deal et al. [24]. The camera has a 14-bit digital output, outputting a unitless spectral
intensity at each pixel with a range between 0 and 16383 (214-1). Each pixel has a size of
8 µm × 8 µm. The hyperspectral filters were tuned to the wavelengths from 360 nm to
550 nm, with a spectral resolution of 5 nm. The band corresponding to the 385 nm
window was not present for each dataset, and has been excluded in this research. The total
number of spectral bands in each hypercube is 38.
The University of Southern Alabama was able to provide 175 hyperspectral tissue
sample images, taken from 13 patients, for this thesis. These images all have a size of
501 × 502 × 38 (for a total of 9,557,076 pixels or features per image). There are 88
images labeled as lesional tissue samples and there are 87 images labeled as nonlesional
tissue samples. The breakdown of these sample hyperspectral tissue images is shown in
Table 1.
Table 1
Breakdown of Tissue Sample Images by Patient
Patient ID Number of Lesional Images Number of Nonlesional Images Total
1 3 2 5
2 5 4 9
3 3 5 8
4 8 6 14
5 9 9 18
6 4 6 10
7 15 6 21
8 9 6 15
9 7 8 15
10 8 12 20
12 10 9 19
13 5 6 11
14 2 8 10
Total 88 87 175
As can be seen from the table, there is a lot of variation in the number of images provided
for each patient, with some patients having as few as 5 images, and others as many as 21.
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And while the proportion of cancerous to noncancerous images varies from patient to
patient, the total data are split almost evenly between the cancerous and noncancerous
images.
There appears to be considerable spectral variation between patients as well. Fig. 7
shows the spectral distribution from lesional samples, with spectra of the same color
coming from the same patient.
Fig. 7. Spectral distribution of lesional images, taken at random pixels.
Fig. 8 shows the spectral distribution of some nonlesional samples, again with spectra
of the same color coming from the same patients. The dotted lines in these figures
correspond to the wavelengths associated with blue, green, and red light. From these
images, it can be seen that the spectral values of tissue samples tend to be highly
correlated between patients, but also differ from patient to patient.
16
Fig. 8. Spectral distribution of nonlesional images, taken at random pixels.
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5 PROPOSED CONVOLUTIONAL NEURAL NETWORK
This chapter discusses the development and implementation of the hyperspectral
classifier. First the datasets being compared are discussed. The preprocessing of the data
is then presented. The system architecture is presented, and finally the chapter discusses
the classifier implementation.
5.1 Data Augmentation and Data Deduction
Three schemes have been developed with the hyperspectral data in order to test the
advantages of the hyperspectral information in classifying these images. The first of these
schemes involves merging all 38 of the 5 nm bands into one grayscale image. These are
the panchromatic (PC) images, and this results in 175 single-channel images. The second
scheme involves each of hyperspectral bands being treated as its own individual grayscale
image. These are the individual band (IB) images, and this results in 6650 single-channel
images. The third scheme involves the complete hypercube (Hyper) images. This group
has 175 hyperspectral images, each with 38 channels. These schemes result in a large
difference in the number of images between them. The PC and Hyper schemes use only
the 175 images, while the IB scheme has 6650 images to train with.
One key assumption is made regarding the tissue samples and these schemes. The
tissue samples were sent to the lab in dishes that were only labeled either “lesional” or
“nonlesional.” From this it is assumed that each tissue sample is homogeneous. It is either
completely ”lesional” or completely ”nonlesional.” Based on this assumption, the PC and
Hyper schemes are each divided into two smaller sets. The first sets are the segmented
hypercubes (SH) and the segmented panchromatic (SPC) schemes, each with 100 × 100
pixel images (4375 images total). The second of these sets are the smaller segmented
hypercubes (SSH) and the smaller segmented panchromatic (SSPC) schemes, with 50 ×
50 pixel images (17500 images total). These five schemes are summarized in Table 2, and
these are used to test the proposed architecture.
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Table 2
Feature Summary of Tissue Sample Schemes
Scheme Total Number of Images Image Dimensions Number of Features
IB 6650 501 × 502 × 1 251502
PC 175 501 × 502 × 1 251502
Hyper 175 501 × 502 × 38 9557076
SPC 4375 100 × 100 × 1 10000
SH 4375 100 × 100 × 38 380000
SSPC 17500 50 × 50 × 1 2500
SSH 17500 50 × 50 × 38 95000
5.2 Data Preprocessing
The preprocessing of the image involves shuffling the dataset, normalizing the dataset,
and flattening and storing the data in an hdf5 file. The patient order is shuffled by a
random seed, and the images are grouped together by patient so the images training the
network are from different patients than the ones validating the network. The patients are
shuffled as shown in Table 3.
Table 3
Patient Order
Validation Fold Patient ID
1 7
2 4
3 12
4 8
5 5
6 14
7 2
8 3
9 6
10 9
11 1
12 10
13 13
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The dataset is then normalized by dividing all of the pixels by the maximum possible
value of the dataset (determined by the maximum possible output of the 14-bit camera
specifications, which is 16383 or 214−1). These images are then flattened and stored in an
hdf5 file before being loaded and trained to the CNN. The lesional images are labeled 0
and the nonlesional images are labeled 1.
5.3 CNN Architecture
These schemes are tested on a CNN made up of three alternating sets of 2-dimensional
convolution layers and max pooling layers. These sets are followed by a fully connected
layer which is connected to the output. This network uses L2 regularization and the
convolutional layers carry out 2-dimensional convolutions (the convolution is only carried
out along the x-axis and y-axis of the image). Each kernel has the same depth as the input
to the convolution layer. The outputs of the convolution and fully connected layer all use
tanh as the activation function. The basic CNN architecture is shown in Table 4.
Table 4
Basic CNN Architecture
CNN Layer Kernel Window Size Stride Feature Maps
Conv+tanh+Drop 5 X 5 X d 3 24
Max Pool 2 X 2 X d 2 24
Conv+tanh+Drop 3 X 3 X d 1 48
Max Pool 2 X 2 X d 2 48
Conv+tanh+Drop 2 X 2 X d 1 64
Max Pool 2 X 2 X d 2 64
FC Layer 24 - -
The first convolutional layer in the table is connected to the input and the fully connected
layer is connected to the output of the network. The table also shows the two-dimensional
filter size and the stride of the filter. Each of the convolutional layers uses zero padding on
the inputs while the max pool layers uses no zero padding.
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5.4 CNN Implementation
This CNN is implemented in Python using Tensorflow with an NVIDIA Tesla K40C
GPU. Since the images from each patient are all from the same tissue sample, there is
high correlation between the images from each patient and each segment. Before being
fed to the network, the images are separated into 13 training and validation folds, and a
variation of the leave one out model evaluation method is used. Leave one patient out
(LOPO) uses the images from 12 of the 13 patients to train a CNN and then tests the
model on the remaining patient’s data.
These models are trained for a set number of epochs, which is determined by an
initial test run for each scheme. The models are trained for enough epochs to ensure that
the network has converged to a stable point. An example of the SSH scheme converging
is shown in Fig. 9.
Fig. 9. Training accuracy per epoch trained for the SSH scheme.
The number of epochs each scheme is trained for is shown in Table 5. These models are
evaluated on the basis of their accuracy, precision, recall, and F1 score. Accuracy
measures the number of correct predictions over the total predictions made. Precision
measures the number of true positives over the total number of positive predictions made.
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Table 5
Training Epochs for Each Scheme
Scheme Training Epochs Run
IB 30
PC 100
Hyper 80
SPC 120
SH 90
SSPC 120
SSH 60
For this dataset, a high precision means that fewer of the cancerous samples are predicted
as noncancerous. Recall measures the number of true positives over the total number of
positives. For this dataset, a high recall means that fewer noncancerous images are being
classified as cancerous. The F1 score is the combination of the precision and recall, using
the harmonic mean.
The performances of the last 20 epochs are averaged together and this is the metric
used to evaluate each model. For the segmented schemes, the validation set segments are
also grouped by the original image, and a final image prediction is made based on the
majority of the segments from that image. A similar method is used for the IB scheme, in
which each image has its bands grouped together and a final prediction is made based on
the majority of the bands.
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6 HYPERSPECTRAL CLASSIFIER PERFORMANCE
This chapter covers the performance of the CNN trained to classify the hyperspectral
colon cancer images. The first section compares the different spectral schemes that have
been used to determine the contribution of the hyperspectral data in classifying the
lesional tissue samples. The next section compares the results from the CNN to different
simple classifiers in order to determine the usefulness of the CNN in classifying the
hyperspectral data. Then the chapter looks at the efforts to fine tune the hyperparameters
of the CNN. The final section further discusses the classifier results.
6.1 Spectral Data Comparison Results
The goal of this thesis is to determine whether the hyperspectral data have been useful
in classifying the colon cancer tissue samples. For this reason, the PC, IB, and Hyper
images and their segmented counterparts (see Section 5.1 for details) are trained on the
CNN architecture discussed in Section 5.3. The results of these models are shown in
Table 6.
Table 6
LOPO Validation Set Results
Models Acceleration Precision Recall F1 Score
IB 0.603 0.609 0.575 0.590
PC 0.530 0.529 0.515 0.521
SPC 0.485 0.480 0.473 0.476
SSPC 0.442 0.439 0.460 0.449
Hyper 0.476 0.467 0.403 0.431
SH 0.630 0.640 0.588 0.612
SSH 0.659 0.689 0.577 0.627
Training using full-sized hyperspectral images does not perform better than the other sets
of networks. However, in this case, the PC and Hyper schemes have a much smaller
number of available images than the IB scheme. Once the images are segmented, then the
hyperspectral data are an improvement when they are compared to the other data schemes.
23
The SSH scheme outperforms each of the other datasets with 65.9% accuracy and an F1
score of 0.627. We believe the overall poor performance of the classifiers is due to the
small number of patients available for this study. Despite this limitation, the SSH scheme
still outperforms the IB scheme by 5.6% (and by a 0.037 F1 score). This shows that the
spectral information present in the hypercube helps determine whether or not the tissue is
cancerous. Table 7 takes a look at the breakdown of the SSH classifier performance by
patient.
Table 7
SSH Performance by Patient
Patient Acceleration Precision Recall F1 Score
1 0.510 0.092 0.125 0.105
2 0.811 0.936 0.588 0.708
3 0.375 0.000 0.000 0.000
4 0.814 0.990 0.575 0.721
5 0.650 0.890 0.339 0.473
6 0.880 1.000 0.800 0.887
7 0.295 0.209 0.642 0.315
8 0.600 0.000 0.000 0.000
9 0.870 0.880 0.875 0.873
10 0.778 0.990 0.638 0.772
12 0.584 0.655 0.639 0.606
13 0.672 0.638 0.958 0.763
14 0.830 1.000 0.788 0.879
Overall 0.659 0.689 0.577 0.627
µ 0.667 0.637 0.536 0.546
σ 0.181 0.394 0.309 0.321
As shown in the table, there is a lot of variation between patients. Some of this is caused
by the number of images the tissue samples from each patient have provided. Another
factor that affects the patient performance is the small number of patients available in the
study. For two patients (patient 3 and patient 8), the model predicts that each image is
lesional.
24
The model performs best on patient 6’s data, with 88% accuracy and 0.887 F1 score.
The model accuracies for the data for patients 2, 4, 9, and 14 are over 80%. On the other
hand, the model accuracies for the data for patients 3 and 7 are below 50%. The results of
these models vary highly from patient to patient. This is due to the small number of
patients available for the study and the high variation between the spectra from each
patient.
The confusion matrix from the SSH LOPO validation set is shown in Table 8. This
classifier tends to misclassify slightly more nonlesional tissue samples than lesional ones.
This observation is similar to the results shown in Leavesley et al. [22]. This might make
the network more useful as a preliminary cancer screening, as the model tends to
misclassify fewer cancerous samples.
Table 8
Confusion Matrix for the SSH LOPO Validation Set
SSH
Predicted Labels
True Labels Lesional Nonlesional
Lesional 65 23
Nonlesional 37 50
6.2 Classifier Data Comparison
One of the goals of this thesis is to determine whether or not the CNN is beneficial in
classifying hyperspectral imaging data. To demonstrate this, the CNN classifier is
compared to a KNN classifier and a logistic regression (LR) classifier, both using the SSH
dataset. The KNN classifier makes predictions based on the K-nearest inputs trained on
the classifier. For this classifier, K=5 is used as the number of nearest neighbors and
Euclidean distance is used when classifying its results. The LR classifier uses the logistic
function to determine the probability that each input belongs to the positive class (the
nonlesional images, in this case).
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The results of this comparison are shown in Table 9. The CNN outperforms the two
simple classifiers, although the LR model is close to the CNN’s performance, with 60.9%
accuracy and a 0.566 F1 score.
Table 9
Simple Classifier Comparison
Models Acceleration Precision Recall F1 Score
KNN (K=5) 0.480 0.478 0.494 0.486
Logistic Regression 0.609 0.631 0.515 0.566
CNN 0.659 0.689 0.577 0.627
The CNN outperforms the KNN model by 17.9% in accuracy and by 0.141 in F1 score.
The CNN outperforms the LR model by 5.0% in accuracy and by 0.061 in F1 score. The
confusion matrix for the LR classifier is shown in Table 10. From this table, we see that
the LR model is still classifying more lesional samples correctly compared to nonlesional
samples.
Table 10
Confusion Matrix for the LR LOPO Validation Set
LR
Predicted Labels
True Labels Lesional Nonlesional
Lesional 62 26
Nonlesional 42 45
6.3 Fine Tuning of CNN
In this section, the CNN fine tuning is presented and the results of the tuning are
discussed. The SSH network is chosen as a baseline and tuned in the several ways.
Models are evaluated on the basis of the activation function used, on the normalization
method used, on the performance of 3-D convolution, on the number of convolution
layers used, on the number of feature maps used, and on the number and size of the of
fully connected layers used. Models using different activation functions, such as tanh,
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relu, elu, and leaky relu are evaluated and the results of these evaluations are shown in
Table 11. While the model using the elu activation function come the closest to matching
the performance of the tanh activation function, it only performs as well as than the LR
classifier from the previous set of models.
Table 11
Activation Function Tuning
Models Acceleration Precision Recall F1 Score
relu 0.546 0.550 0.486 0.515
leaky relu (α=0.3) 0.569 0.574 0.515 0.542
leaky relu (α=0.4) 0.560 0.564 0.509 0.535
leaky relu (α=0.5) 0.571 0.577 0.510 0.541
elu 0.615 0.636 0.534 0.579
tanh 0.659 0.689 0.577 0.627
Models using different methods of data normalizing are also examined. The baseline
network normalizes the images based on the values of the camera output. Since this was a
14-bit camera, the maximum value of 16383 is used normalize each pixel to a value
between 0 and 1. For these evaluations, we compare our original normalization method to
a method normalizing each image based on the values of the image (min-max
normalization) and to a method dividing each image by the maximum value for each
image. The results of these evaluations are shown in Table 12.
Table 12
Normalization Tuning
Models Acceleration Precision Recall F1 Score
Image Max 0.525 0.525 0.468 0.494
Image Normalization 0.535 0.536 0.475 0.503
Dataset Normalization 0.659 0.689 0.577 0.627
Neither of the two image-based normalization methods perform well on the SSH dataset,
with the Image Max model having an accuracy of 52.5% and the Image Normalization
model having an accuracy of 53.6%.
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The baseline model using 2-D convolution layers is compared to two models using
3-D convolution. The first model uses fewer feature maps in the second and third
convolution-max pool layer pair. The second 3-D model keeps the same number of feature
maps as the baseline model. The results of these evaluations are shown in Table 13.
Table 13
3-D Convolution Comparison
Models Acceleration Precision Recall F1 Score
2-D Convolution 0.659 0.689 0.577 0.627
3-D Convolution 1 0.507 0.508 0.288 0.367
3-D Convolution 2 0.488 0.483 0.408 0.436
Neither of the 3-D convolution layer models fare well, with the first 3-D convolution
model having an accuracy of 50.7% and the second 3-D convolution model having an
accuracy of 48.8%. More work will need to be done to properly evaluate the performance
of the 3-D convolution layers.
The number of convolution layers for this classifier is also examined, with a
comparison of the baseline model to models using 2 convolution-max pool layer pairs and
4 convolution-max pool layer pairs. The 4-layer model creates the extra pair by
duplicating the third layer and the 2-layer model deletes the second pair of layers. The
results of these evaluations are shown in Table 14.
Table 14
Convolution Layer Comparison
Models Acceleration Precision Recall F1 Score
2 Convolution and Max Pool Layers 0.569 0.586 0.453 0.509
3 Convolution and Max Pool Layers 0.659 0.689 0.577 0.627
4 Convolution and Max Pool Layers 0.578 0.577 0.566 0.571
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Changing the number of convolution layers does little to help the classifier performance.
The model built with two convolution-max pool layers has an accuracy of 56.9%. The
model built with four convolution-max pool layers has an accuracy of 57.8%.
Models are also developed to determine the optimal number of feature maps, and the
results of these evaluations are shown in Table 15. Tuning the feature maps does little to
the CNN performance. The model with half the feature maps had a 64.2% accuracy,
underperforming the baseline model by 1.7%. The model with twice the feature maps had
a 61.2% accuracy, underperforming the baseline model by 4.7%.
Table 15
Feature Map Comparison
Models Acceleration Precision Recall F1 Score
1/2 Baseline 0.642 0.665 0.563 0.609
Baseline 0.659 0.689 0.577 0.627
2 × Baseline 0.612 0.630 0.539 0.580
The last set of evaluations compare the number fully connected layers (FC) at the
output of the network. The model with two FC has 36 neurons in the first layer and 24 in
the second. The model with the bigger FC has 36 neurons, while the model with the
smaller FC has 12 neurons. The results of this evaluation are shown in Table 16.
Table 16
Fully Connected Layer Comparison
Models Acceleration Precision Recall F1 Score
Smaller FC 0.658 0.683 0.588 0.630
Baseline 0.659 0.689 0.577 0.627
Bigger FC 0.653 0.671 0.596 0.630
2 FC 0.645 0.667 0.574 0.615
The model with the smaller FC comes closest to the baseline model, with an accuracy of
65.8%, but has a slightly higher F1 score, with a score of 0.630. This model seems to be
slightly more fair than the baseline model. The model with the bigger FC had an accuracy
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of 65.3%, with an F1 score of 0.630. The model with the second FC layer has an accuracy
of 64.5%, with an F1 score of 0.615.
None of these methods for fine tuning the model have done much to improve the
model. Again, this is due to the model being at the limits of what can be done with the
current small patient set. More data will be needed to build a better, more accurate
network.
6.4 Further Discussion
This section looks at some of the spectra of the classified and misclassified images
and takes a deeper look at the best and worst performing patient data from the classifier.
Here are some of the spectra from the correctly classified and the misclassified images.
Fig. 10 and Fig. 11 both show spectra from tissue samples that were correctly identified
by the baseline SSH classifier.
Fig. 10. Spectra from correctly identified lesional tissue samples.
Each color spectra represents spectra from the same patient. The dotted lines correspond
to the wavelengths associated with blue, green, and red light. These two figures both
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appear similar, except for a small spike in the blue wavelength range in the nonlesional
spectra. We believe that this similarity may explain some of the difficulty in classifying
hyperspectral data. This also demonstrates the challenge in processing hyperspectral data
and why machine learning tools such as CNNs are needed to dig deeper into the data.
Fig. 11. Spectra from correctly identified nonlesional tissue samples.
We take a look at some of the errors in the network to better understand the CNN’s
performance. Fig. 12 and Fig. 13 both show spectra from tissue samples that were
misclassified by the baseline SSH classifier. Again, each color spectra represents spectra
from the same patient and the dotted lines correspond to the color of light for that
wavelength. The spectra from the misclassified lesional images appear to share some of
the same blue wavelength spike as the nonlesional spectra. The spectra misclassified as
nonlesional appear to be flatter, except for two spectra that are much higher than the
others. Still, it is hard to draw meaningful conclusions from these errors.
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Fig. 12. Spectra from misidentified lesional tissue samples.
Fig. 13. Spectra from misidentified nonlesional tissue samples.
The model performs the worst against patient 3’s data (Validation fold 8) when
compared to each of the other patients’ data. The model classifies every image segment of
patient 3’s data as lesional. To examine this, Fig. 14 looks at spectra from every
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nonlesional image in patient 3’s data. The spectra from the same image are represented as
the same color. This figure shows spectra from each of the 5 nonlesional images from
patient 3’s data. Next this is compared to the lesional spectra from patient 3’s data, shown
in Fig. 15.
Fig. 14. Spectra from patient 3’s nonlesional images (Validation fold 8).
Fig. 15. Spectra from patient 3’s lesional images (Validation fold 8).
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The data for patient 3 have 3 lesional images, and spectra from each image is shown as a
different color. There appears to be little differentiating the two sets, which may explain
why they are all classified one way. The spectra from both these sets of data seem to have
much higher spectral intensities in the 350 nm to 400 nm range than the other spectra
shown in this section. It is possible that the data from patient 3 are an outlier and the
extremely high spectral values in the ultraviolet portion of the spectrum are causing
problems for the CNN.
Next we examine the data that fit the best to our model. The model performs best with
the data for patient 6 compared to the data for the other patients. Not only does this fold
have 88% accuracy, but its precision is 1, meaning no lesional samples are mistakenly
classified as nonlesional. Fig. 16 shows spectra from the 6 nonlesional images in patient
6’s data, color coded by the different images.
Fig. 16. Spectra from Patient 6 (Validation fold 9) nonlesional sample.
This is compared to Fig. 17, which shows spectra from the 4 lesional images in patient 6’s
data.
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Fig. 17. Spectra from Patient 6 (Validation fold 9) lesional sample.
Both of these sets of images for patient 6’s data contain much lower spectral intensities
than the images for patient 3’s data. These are closer to the typical spectra that were
shown before. The images show that the cancerous images have a higher spike in the blue
portion of the spectrum. However, the lesional images from patient 6’s data seem to have
lower intensities overall.
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7 FUTURE WORK
One of the main problems with this dataset is the small number of patients. The two
main paths of future work involve ways that could improve the usefulness of the CNN
classifier if a larger pool of patient images becomes available, and the paths that could
improve the usefulness of the model if the number of patients remains small.
If more patients can be studied, then the first major area of exploration would involve
developing 3-D convolution layers to better tease out the differences in the spectra.
Current exploration into these convolutional networks did not yield much success, but
further study would be required to know whether or not they can improve the
classification process. There is reason to believe with the importance of the spectral
information that the 3-D kernel may ultimately be better attuned to capturing these
changes. The second major area of exploration would be the use of PCAs with the
hyperspectral images. PCAs are often useful in indicating which features contribute most
to an output, and they could be useful for indicating which bands tend be more active in
the cancerous cells. PCAs could also be used in tandem with CNNs in order to reduce the
number of features of a hyperspectral image. In addition to these ideas, further data
augmentation might be feasible. While the current use of image segmentation may have
been pushed to its limits, with an increased patient pool, other data augmentation methods
may be worth exploring.
If the number of patients in the hyperspectral dataset remains small, a different set of
paths will need to be explored. In the case of small datasets like the one available for this
thesis, transfer learning can be a useful tool for building new models. While most of the
publicly available datasets involve typical 3-channel images, if used in conjunction with
other machine learning tools like PCAs, the hyperspectral images might be applicable to
those networks as well. There may be possible ways to combine the hyperspectral
information with information found in common grayscale colonoscopy images and other
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common medical tools. These could be used with PCAs and other current hyperspectral
fusion methods to build up a better network for the classifier with the limited information
available.
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8 CONCLUSIONS
This thesis demonstrated that information from hyperspectral data were able to
increase the performance of the developed colon cancer sample classifier. It was shown
that the SSH dataset had a 5.6% improvement in accuracy and a 0.037 F1 score
improvement over models using grayscale images. It also showed how CNNs were useful
in better classifying the hyperspectral data, as the CNN showed a 5% accuracy
improvement and a 0.061 F1 score improvement over the simpler classifiers such as KNN
and LR classifiers.
One of the factors limiting the performance of this system is the current number of
patients available for this study. With the high variability between patients, one the most
important things to do to improve the system would be to get more patients into the study,
either through more hyperspectral studies or through data fusion with current colonoscopy
methods.
Once further researched, hyperspectral imaging could become a critical tool in
catching colon cancer in its earlier stages. In the future, understanding the spectral
makeup of these tumorous cells could make it easier to detect cancer before it grows to
the point that it becomes life-threatening.
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